The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now ...

Technology & Telecommunication Acquisition Corp (NASDAQ:TETE), a special purpose acquisition company, has been notified of its pending delisting from the Nasdaq Stock Market due to non-compliance with ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.

When it comes to stock market debuts, 2024 was not an active year for many industries, not least cross-border payments, but ...

Loeb & Loeb, which launched a Beijing office in 2008, has been playing the long game and is now outgunning the likes of Skadden, Kirkland and Davis Polk for work on U.S. IPOs issued by Asia-based ...

Private equity is looking at a better year with growth engines for investments, and better exits from lowered expectations, ...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...